IXICO plc (AIM: IXI)
London
· Delayed Price · Currency is GBP · Price in GBX 12.26
+0.26 (2.17%)
Jan 20, 2025, 11:54 AM GMT+1
IXICO Revenue
In the fiscal year ending September 30, 2024, IXICO had annual revenue of 5.77M GBP, down -13.49%. IXICO had revenue of 3.23M in the half year ending September 30, 2024, a decrease of -31.62%.
Revenue
5.77M
Revenue Growth
-13.49%
P/S Ratio
1.01
Revenue / Employee
71.19K
Employees
81
Market Cap
11.12M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 5.77M | -899.00K | -13.49% |
| Sep 30, 2023 | 6.67M | -1.98M | -22.89% |
| Sep 30, 2022 | 8.64M | -547.00K | -5.95% |
| Sep 30, 2021 | 9.19M | -342.00K | -3.59% |
| Sep 30, 2020 | 9.53M | 1.97M | 26.07% |
| Sep 30, 2019 | Pro | Pro | Pro |
| Sep 30, 2018 | Pro | Pro | Pro |
| Sep 30, 2017 | Pro | Pro | Pro |
| Sep 30, 2016 | Pro | Pro | Pro |
| Sep 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 38.20B |
| GSK plc | 31.31B |
| Haleon | 11.24B |
| Smith & Nephew | 4.46B |
| ConvaTec Group | 1.74B |
| Hikma Pharmaceuticals | 2.39B |
| HUTCHMED (China) | 483.31M |
| Oxford Nanopore Technologies | 167.75M |
IXICO News
- 6 weeks ago - IXICO PLC (FRA:PYPB) (Q4 2024) Earnings Call Highlights: Strong Revenue Growth and Strategic ... - GuruFocus
- 6 weeks ago - Full Year 2024 IXICO PLC Earnings Call Transcript - GuruFocus
- 2 months ago - Small Cap Stocks: Eco Buildings, IXICO, Electric Guitar - The Armchair Trader